NASDAQ:DARA - DARA Biosciences Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding DARA Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.44 0.00 (0.00 %) (As of 11/27/2019) Add Today's Range$0.44Now: $0.44▼$0.4450-Day Range$0.32MA: $0.32▼$0.3352-Week Range$0.67Now: $0.44▼$1.05Volume56,253 shsAverage Volume118,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company's primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:DARA Previous Symbol CUSIPN/A CIK919745 Webhttp://www.darabiosciences.com/ Phone+1-816-9147027Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive DARA News and Ratings via Email Sign-up to receive the latest news and ratings for DARA and its competitors with MarketBeat's FREE daily newsletter. DARA Biosciences (NASDAQ:DARA) Frequently Asked Questions What is DARA Biosciences' stock symbol? DARA Biosciences trades on the NASDAQ under the ticker symbol "DARA." How were DARA Biosciences' earnings last quarter? DARA Biosciences Inc (NASDAQ:DARA) issued its earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). The specialty pharmaceutical company earned $1.18 million during the quarter, compared to the consensus estimate of $0.83 million. View DARA Biosciences' Earnings History. Has DARA Biosciences been receiving favorable news coverage? News coverage about DARA stock has been trending extremely negative on Saturday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. DARA Biosciences earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave news headlines about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for DARA Biosciences. What other stocks do shareholders of DARA Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other DARA Biosciences investors own include Castleton Technology (CTP), Richland Resources (RLD), THOR MINI/PAR VTG FPD 0.0001 (THR), Global Invacom Group (GINV), Legendary Investments (LEG), Octagonal (OCT), iPass (IPAS), Clontarf Energy (CLON), Starcom (STAR) and AEterna Zentaris (AEZS). What is DARA Biosciences' stock price today? One share of DARA stock can currently be purchased for approximately $0.44. What is DARA Biosciences' official website? The official website for DARA Biosciences is http://www.darabiosciences.com/. How can I contact DARA Biosciences? DARA Biosciences' mailing address is 8601 Six Forks Rd Ste 160, RALEIGH, NC 27615-2965, United States. The specialty pharmaceutical company can be reached via phone at +1-816-9147027. MarketBeat Community Rating for DARA Biosciences (NASDAQ DARA)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 106 (Vote Outperform)Underperform Votes: 80 (Vote Underperform)Total Votes: 186MarketBeat's community ratings are surveys of what our community members think about DARA Biosciences and other stocks. Vote "Outperform" if you believe DARA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DARA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/7/2019 by MarketBeat.com StaffFeatured Article: Why does a company issue an IPO?